October 14, 2020
Cue Health, a rapid diagnostics startup with a connected testing device platform, has been awarded $481 million from HHS and the Department of Defense (DoD) to expand production of a COVID-19 molecular test that received an Emergency Use Authorization back in June.
According to announcements from the government and the startup, the money will be used to deliver six million COVID-19 molecular...
June 10, 2020
Cue Health, a rapid diagnostics startup now working on a connected testing device, has closed $100 million in a Series C round announced this morning. Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and other unnamed investment firms all participated in the raise.
WHAT THEY DO
The San Diego-based company's leading product is the Cue...